United States ENT Diagnostic Devices Market Outlook to 2025

  • ID: 4494878
  • Report
  • Region: United States
  • 74 pages
  • GlobalData
1 of 4
United States ENT Diagnostic Devices Market Outlook to 2025

Summary

The new report, "United States ENT Diagnostic Devices Market Outlook to 2025", provides key market data on the United States ENT Diagnostic Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Audiometers, Auditory Brainstem Response Analyzers, Tympanometers, Otoacoustic Emissions Analyzers, Otoscopes

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for ENT Diagnostic Devices market segments - Audiometers, Auditory Brainstem Response Analyzers, Tympanometers, Otoacoustic Emissions Analyzers, Otoscopes.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for ENT Diagnostic Devices market.
  • Global corporate-level profiles of key companies operating within the United States ENT Diagnostic Devices market.
  • Key players covered include William Demant Holding A/S, Natus Medical Incorporated, Hill-Rom Holdings Inc. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Diagnostic Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Diagnostic Devices Market, United States
3.1 Diagnostic Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Otoscopes Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Diagnostic Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Otoscopes Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Diagnostic Devices Market, United States, Average Price ($), 2015-2025
3.4 Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in United States, Diagnostic Devices Market
4.1 William Demant Holding A/S
4.1.1 Company Overview
4.2 Natus Medical Incorporated
4.2.1 Company Overview
4.3 Hill-Rom Holdings Inc
4.3.1 Company Overview
4.4 Heine Optotechnik GmbH & Co KG
4.4.1 Company Overview
4.5 Benson Medical Instruments Company
4.5.1 Company Overview

5 Diagnostic Devices Market Pipeline Products

6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Stryker to Acquire Entellus Medical for USD662 Million
6.1.2 Entellus Medical Acquires Spirox from KKR Fund for USD81 Million
6.2 Equity Offerings
6.2.1 Entellus Medical Plans to Raise up to USD172.3 Million in Public Offering of Shares
6.2.2 Entellus Medical Raises USD50 Million in Private Placement of Shares
6.3 Venture Financing
6.3.1 Preceptis Medical Raises USD0.2 Million in Venture Financing
6.3.2 Preceptis Medical Raises Funds through Series B Financing
6.3.3 Preceptis Medical to Raise USD1 Million in Venture Financing
6.3.4 Tusker Medical Raises USD10.2 Million in Venture Financing

7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 05, 2018: Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit
7.1.2 Dec 21, 2017: PENTAX Medical Names Veteran Executive as The Americas Region President and CEO
7.1.3 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
7.1.4 Nov 21, 2017: Vickie Capps Joins OmniGuide’s Board of Directors
7.1.5 Oct 25, 2017: Notal Vision Welcomes Distinguished Retinal Specialist John S. Pollack, MD, to the Board of Directors
7.1.6 Sep 29, 2017: Dr. Nabil El-Hag Appointed Managing Director and Co-Chairman of TecPort Vision as Company Prepares for Global Expansion into the Multi-Billion Dollar Migraine Industry
7.1.7 Aug 23, 2017: OmniGuide Appoints Ajay Bhave as its Chief Technology Officer
7.1.8 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
7.1.9 Aug 01, 2017: Notal Vision Welcomes Roni Amiel as Chief Information Officer
7.1.10 Jul 24, 2017: Notal Vision Names Jim Long as Chief Financial Officer
7.1.11 Jul 20, 2017: Teresa L. Kline Joins Intersect ENT’s Board of Directors
7.1.12 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact
7.1.13 May 02, 2017: Medline Names New President of Canadian Business
7.1.14 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech
7.1.15 Mar 06, 2017: Medline Announces New Chief Marketing Officer
7.2 Financial Announcements
7.2.1 Feb 07, 2018: Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results
7.2.2 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
7.2.3 Jan 09, 2018: Stryker provides 2017 preliminary net sales results
7.2.4 Jan 08, 2018: Intersect ENT Reports Preliminary Q4 and Year 2017 Revenue
7.2.5 Jan 08, 2018: Natus Medical Announces 2018 Annual and First Quarter Financial Guidance
7.2.6 Nov 02, 2017: Intersect ENT Reports Third Quarter 2017 Results
7.2.7 Nov 01, 2017: Entellus Medical Announces Third Quarter 2017 Financial Results
7.2.8 Oct 26, 2017: Stryker reports third quarter 2017 results
7.2.9 Oct 25, 2017: Natus Medical Announces Third Quarter 2017 Financial Results
7.2.10 Aug 03, 2017: Entellus Medical Announces Second Quarter 2017 Financial Results
7.2.11 Aug 01, 2017: Intersect ENT Reports Second Quarter 2017 Results
7.2.12 Jul 27, 2017: Stryker reports second quarter 2017 results
7.2.13 Jul 26, 2017: Natus Medical Announces Second Quarter 2017 Financial Results
7.2.14 Jun 28, 2017: GenePeeks Announces Partnership with The World Egg Bank
7.2.15 May 08, 2017: Fibrocell Announces Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
7.2.16 May 03, 2017: Entellus Medical Announces First Quarter 2017 Financial Results
7.2.17 May 02, 2017: Intersect ENT Reports First Quarter 2017 Results
7.2.18 Apr 26, 2017: Natus Medical Announces First Quarter 2017 Financial Results
7.2.19 Apr 25, 2017: Stryker reports first quarter 2017 results
7.2.20 Feb 28, 2017: Intersect ENT Reports Fourth Quarter and Full Year 2016 Results
7.2.21 Feb 27, 2017: Aurobindo Receives FDA Approval for Dalfampridine Extended-Release Tablets, 10 mg
7.3 Government and Public Interest
7.3.1 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
7.4 Legal And Regulatory
7.4.1 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience
7.4.2 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa
7.4.3 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates
7.4.4 Sep 01, 2017: Minnetronix Maintains Perfect Record with Seventh FDA Inspection
7.4.5 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
7.4.6 May 23, 2017: KARL STORZ Wins Inter Partes Review Trial Invalidating Novadaq Patent
7.5 Other Significant Developments
7.5.1 Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes
7.5.2 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery
7.5.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia
7.6 Product News
7.6.1 Apr 21, 2017: Optim Provides Technology Support for Otolaryngology Society Annual Conference
7.6.2 Feb 28, 2017: Scopis Receives FDA 510(K) and Health Canada MDL Clearance for Its Cutting-Edge Surgical Navigation System for ENT Surgery
7.7 Strategy And Business Planning
7.7.1 Jul 10, 2017: Facility Expansion and Leadership Appointment Signal Growth for Minnetronix
7.7.2 Jul 01, 2017: Dale Medical Products Announced its Relocation

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Diagnostic Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Diagnostic Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Otoscopes Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Otoscopes Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Diagnostic Devices Market, United States, Volume (Units), 2015-2020
Table 6: Diagnostic Devices Market, United States, Volume (Units), 2021-2025
Table 7: Otoscopes Market, United States, Volume (Units), 2015-2020
Table 8: Otoscopes Market, United States, Volume (Units), 2021-2025
Table 9: Diagnostic Devices Market, United States, Average Price ($), 2015-2020
Table 10: Diagnostic Devices Market, United States, Average Price ($), 2021-2025
Table 11: Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 12: Diagnostic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 13: Diagnostic Devices Market Pipeline Products
Table 14: Stryker to Acquire Entellus Medical for USD662 Million
Table 15: Entellus Medical Acquires Spirox from KKR Fund for USD81 Million
Table 16: Entellus Medical Plans to Raise up to USD172.3 Million in Public Offering of Shares
Table 17: Entellus Medical Raises USD50 Million in Private Placement of Shares
Table 18: Preceptis Medical Raises USD0.2 Million in Venture Financing
Table 19: Preceptis Medical Raises Funds through Series B Financing
Table 20: Preceptis Medical to Raise USD1 Million in Venture Financing
Table 21: Tusker Medical Raises USD10.2 Million in Venture Financing

List of Figures
Figure 1: Diagnostic Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Otoscopes Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Diagnostic Devices Market, United States, Volume (Units), 2015-2025
Figure 4: Otoscopes Market, United States, Volume (Units), 2015-2025
Figure 5: Diagnostic Devices Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • William Demant Holding A/S
  • Natus Medical Incorporated
  • Hill-Rom Holdings Inc
  • Heine Optotechnik GmbH & Co KG
  • Benson Medical Instruments Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll